Epigenetic Regulation of Cancer in Response to Chemotherapy: Advances in Cancer Research

By Joseph Landry, this volume of the Advances in Cancer Research series delves into the latest advancements in the field of epigenetic regulation of cancer in response to chemotherapy. It covers a range of timely topics that are crucial for understanding the complex relationship between epigenetics and cancer treatment.

Key Topics Covered

This book includes chapters on:

• Epigenetically Programmed Resistance to Chemotherapy and Promotion of Immune Evasion in Cancer
• A Role for the Epigenome in Cancer Cell Drug Tolerance
• Histone Methylation and X Chromosomal Genes in Metastasis of Breast Cancer
• Targeting Epigenetic Regulation Using Small Molecule Inhibitors
• Histone Deacetylase Inhibitors as Sanguine Epigenetic Therapeutics against Pugnacious Lung Cancer
• From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia)
• Predictive Models of Chemoresistance Generated by Crunching the Public Drug Screen
• Epigenomic and Genomic Profiling Datasets via Regression-, Machine Learning, and Knowledge-Based Methods
• Probing on the Mechanisms of lncRNAs on Cancer Drug Resistance
• Drug Tolerant Persister Cells in Cancer: Current Knowledge and Therapeutic Perspectives

Why This Book Matters

Epigenetic Regulation of Cancer in Response to Chemotherapy offers insights into the cutting-edge research in the field of cancer treatment. It provides the authority and expertise of leading contributors from an international board of authors, making it a valuable resource for researchers, oncologists, and students interested in the latest developments in cancer research.

Publication Details

Published by Elsevier Science on March 27, 2023, this book is available in English. The ISBNs are 9780443194184 and 9780443194191.